SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001818382-22-000163
Filing Date
2022-09-19
Accepted
2022-09-19 16:39:40
Documents
1
Group Members
AYABUDGE LLCBRADY W DOUGAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A humaschedule13d_a1.htm SC 13D/A 115779
  Complete submission text file 0001818382-22-000163.txt   117188
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Subject) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91701 | Film No.: 221251002
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 35 WILSHIRE ROAD GREENWICH CT 06831
Business Address
Niklason Laura E (Filed by) CIK: 0001878075 (see all company filings)

Type: SC 13D/A